Skip to main content
The George Institute for Global HealthThe George Institute for Global Health
Covid-19 Covid 19 Covid 19
Donate

Social links Global

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
The George Institute for Global Health
  • About us
    • Our Mission And Values
    • Our Strategy
    • Our History
    • How Our Research Is Different
    • Our People
    • Board Of Directors
    • Global Advisory Committee (ACRIS)
    • Our Affiliates And Collaborators
    • George Health
    • Annual Reports
    • Financial Statements
    • Environmental Sustainability Commitment
  • Our Work
    • Our Priorities
    • Better Treatments
    • Better Care
    • Healthier Societies
    • Ongoing Projects
    • Archived Projects
    • Publications
  • News & Events
    • Media Releases
    • News Stories
    • Media Coverage
    • Media Enquiries
    • Events
    • Past Events
    • Blogs / Profile Stories
    • E-Newsletters
    • Videos
    • Podcasts
  • Our Impact
    • Impacting Policy And Practice
    • Reports And Recommendations
    • Case Studies And Examples
    • 20 Years Of Impact
    • Advocacy Networks And Partners
    • Advocacy And Thought Leadership
    • Disruptive Social Entrepreneurship
  • Careers & studies
    • The George Experience
    • Research Training Programs
    • Current Job Opportunities
  • Contact Us
  • Get involved
    • Giving Opportunities
    • Building Back Better After COVID-19: The Research Agenda
    • Reclaiming Comprehensive Public Health: A Call to Action
    • Universal Health Coverage: A Call To Action
    • Join Us Register

    Donate

  • Donate
  1. Home
  2. Publications

The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics

Authors
V Perkovic
Type of Publication
Journal Article
Year of Publication
2021
Journal
American Journal of Nephrology
Language
Eng
Links to full text
  • Google Scholar
  • BibTeX
  • EndNote X3 XML
  • EndNote 7 XML
  • Endnote tagged
  • Marc
  • RIS
Search Publications

Latest Publications

  • A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP-HEPC trial)

    Journal of Viral Hepatitis

    2021

  • The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics

    American Journal of Nephrology

    2021

  • Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

    LANCET NEUROLOGY

    2021

  • Estimating the potential impact of the Australian government's reformulation targets on household sugar purchases.

    Int J Behav Nutr Phys Act

    2021

View all
  • About us
  • Our Work
  • News & Events
  • Our Impact
  • Careers & studies
  • Get involved
  • Thought leadership
  • Contact us
  • Donate

The George Institute for Global Health

Level 5, 1 King Street
Newtown NSW 2042 Australia
Tel: +61 2 8052 4300
Fax: +61 2 8052 4301
info@georgeinstitute.org

The George Institute country sites:

  • The George Institute country sites:
  • Australia
  • China
  • India
  • UK
  • Affiliated with UNSW Sydney

Social links Global

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Subscribe to our E-newsletter

Acknowledgement of Country

The George Institute acknowledges the Gadigal People of the Eora Nation as the Traditional Custodians of the land on which our Australia office and Global Headquarters are built. We pay our respect to Elders past, present and emerging.

Copyright © 2021 The George Institute

Footer Links

  • Disclaimer
  • Privacy policy
  • Data sharing policy
  • Whistleblower policy
  • Modern slavery statement
  • Research code policy
  • PHS awards financial COI policy
  • Sitemap